In the Field of Clinical Examination, the Measurement of Creatine

Total Page:16

File Type:pdf, Size:1020Kb

In the Field of Clinical Examination, the Measurement of Creatine J. Clin. Biochem. Nutr., 3, 17-25, 1987 Bacterial Glucokinase as an Enzymic Reagent of Good Stability for Measurement of Creatine Kinase Activity Hitoshi KONDO, * Takanari SHIRAISHI, Masao KAGEYAMA, Kazuhiko NAGATA, and Kosuke TOMITA Research and Development Center, UNITIKA Ltd., Uji 611, Japan (Received January 10, 1987) Summary An enzymic reagent, that has long-term stability even in the liquid state, was successfully employed for the measurement of serum creatine kinase (CK, EC 2.7.3.2) activity. The enzyme used was the thermostable glucokinase (GlcK, EC 2.7.1.2) obtained from the thermo- phile Bacillus stearothermophilus. The reagent was found to be stable in solution for about one month at 6•Ž and for about one week at 30•Ž. This substitution of glucokinase for the hexokinase of the most commonly used hexokinase-glucose-6-phosphate dehydrogenase (HK-G6PDH) method results in a remarkable improvement of the method. The CK activity measured by the GlcK-G6PDH method was linear up to about 2,000 U/ liter at 37•Ž. The GlcK-G6PDH method was found to give a satisfactory precision and reproducibility (coefficient of variation less than 2.17%). Over a wide range of CK activity, an excellent agreement was obtained between the GlcK-G6PDH and the HK-G6PDH methods. Furthermore several coexistents and anticoagulants were found to have little effect on the measured value of CK activity by the GlcK-G6PDH method. Key Words: creatine kinase activity, glucokinase, improved stability of reagent, creatine kinase determination, thermostable enzyme In the field of clinical examination, the measurement of creatine kinase (CK, ATP : creatine phosphotransferase, EC 2.7.3.2) activity in serum is one of the important examinations usually employed for diagnosis of cardiac diseases such as myocardial infarction or muscular diseases such as progressive muscular dystrophy. Numerous methods have been so far reported for the measurement of CK activity in serum. The most common method used nowadays is the hexokinase *To whom correspondence should be addressed . 17 18 H. KONDO et al. (HK)-glucose-6-phosphate dehydrogenase (G6PDH) method, because it is based on the most reasonable principle and has satisfactory sensitivity and reproducibility. Even since the first report on the HK-G6PDH method by Oliver [1], various im- provements have been made [2-16]. For example, there have been studies on the compounds inhibiting adenylate kinase, which exists in blood and causes a negative error in the HK-G6PDH method [7, 8, 13, 16], on the compounds containing thiol groups for activation of CK activity [10, 12], on the compounds chelating metal ions [11, 14], and the like. As a result, the HK-G6PDH method has been established as the most reliable method for the measurement of CK activity in the clinical labo- ratory. However, the HK-G6PDH method still has the problem that the enzymic reagent used for measuring CK activity has poor stability in the liquid state. Hence, once the assay mixture is prepared, it cannot be used for a long period of time, presumably due to the instability of HK. Recently, Kamei et al. has reported the isolation of the thermostable enzyme glucokinase (G1cK, EC 2.7.1.2), which is similar to HK in the enzymic reaction, from the moderate thermophilic bacterium Bacillus stearothermophilus and its superiority to HK in the enzymic properties [17]. The thermostable G1cK was successfully applied to the reagent for measuring glucose in the biological fluids and the working solution of the reagent consisting of G1cK was reported to be far more stable than that of the reagent consisting of HK [18]. Based on these findings, the authors aimed to develop a stable reagent for measuring serum CK activity by using G1cK insteadd of HK, in order to overcome the above-mentioned disadvantage encountered in the HK-G6PDH method. MATERIALSAND METHODS Materials. G1cK was purified from B. stearothermophilus according to the method of Kamei et al. [17]. G6PDH from Leuconostoc mesenteroides, N-acetyl-L- cysteine (NAC), P1,P5-di(adenosine-5'-)pentaphosphate trilithium salt (Ap5A), disodium salt of AMP, ATP, and NADP+, potassium salt of ADP, and creatine phosphate disodium salt were purchased from Boehringer Mannheim GmbH, Mannheim. Magnesium acetate, imidazole, sodium oxalate, sodium citrate, and lithium lactate were purchased from Wako Pure Chemical Industries, Ltd., Osaka. Disodium salt of EDTA, glucose, reduced form of glutathione, sodium L-ascorbate, and sodium pyruvate were obtained from Ishizu Seiyaku Co., Ltd., Osaka. Heparin sodium salt, sodium fluoride, sodium urate, and 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB) were also obtained from Nakarai Chemicals, Ltd., Kyoto. Hemoglobin of human origin (H 7379) was purchased from Sigma Chemical Co., St. Louis, Mo. Bilirubin control was obtained from Eiken Chemical Co., Ltd., Tokyo. The other chemicals used were obtained from Boehringer Mannheim GmbH, Mann- heim and Wako Pure Chemical Industries, Ltd., Osaka. The CK measuring kit (HK-G6PDH method, NAC activated) based on the J. Clin. Biochem. Nutr. DETERMINATION OF CREATINE KINASE ACTIVITY WITH GLUCOKINASE 19 recommendations by the German Society for Clinical Chemistry was also purchased from Boehringer Mannheim GmbH, Mannheim. Serum samples were obtained from our hospital. Fixed amounts of several coexistents and anticoagulants were mixed in advance with serum samples, and the resultant mixtures were used as the serum sample for the experiments on the effects of coexistents and anticoagulants on the measured value of CK activity. Determination of the activities of GIcK and G6PDH. The activity of G1cK was measured at pH 9.0 with the assay mixture containing 4 mM ATP, 12 mM glucose, 0.9 mM NADP+, about 0.7 U/mi G6PDH from yeast, and 20 mM mag- nesium chloride. The activity of G6PDH was also measured at pH 9.0 with the assay mixture containing 2.64 mM glucose-6-phosphate, 0.9 mM NADP+, and 40 mM magnesium chloride. One unit of G1cK or G6PDH activity was defined as the amount of G1cK or G6PDH that forms 1 pmol of glucose-6-phosphate or 6- phosphogluconolactone in 1 min at 30°C. Determination of the amounts of creatine phosphate, NADP+, and NAC. Crea- tine phosphate and NADP+ were spectrophotometrically measured according to the methods of Lamprecht et al. [19] and Klingenberg [20], respectively. NAC was measured with 0.25 mM DTNB in a 50 mM potassium phosphate buffer (pH 7.5) by using the molar extinction coefficient of the product (13.6 x 103 liter•mol-1• cm-1 at 412 nm). Determination of CK activity. The CK activity in the serum sample was measured at 37°C both with a single reagent which containing all components and with two-separate reagents in which components except for creatine phosphate were contained in the first reagent and creatine phosphate in the second reagent. Unless otherwise stated, the final concentrations of reagent components were as follows : 86 mM imidazole-acetate buffer (pH 6.7), 3.0 U/mi Gick, 1.0 U/ml G6PDH, 25 mM creatine phosphate, 1.5 mM ADP, 20 mM glucose, 2.0 mM NADP+, 20 mM NAC, 10 mM magnesium acetate, 2.0 mM EDTA, 5.0 mM AMP, and 10 pM Ap5A. In the single reagent method, 20 pl of the serum sample was added to 500 pl of the mixture, which had been kept at 37°C, and the reaction rate was immediately monitored at 340 nm with a Gilford 2600 Spectrophotometer. In the method utilizing two-separate reagents, 15-20 pl of the serum sample was added to 400 pl of the first reagent, followed by the addition of 100 pl of the second reagent to start the reaction by CK. The instruments used for the latter method were a Gilford 2600 Spectrophotometer and a Hitachi 105-50 Clinical Spectrophotometer. RESULTS AND DISCUSSION GlcK G6PDH method for the determination of CK activity The principle of the determination of CK activity in the GIcK-G6PDH method can be represented as follows : CK Creatine phosphate + ADP --- Creatine + ATP (1) Vol. 3, No. 1, 1987 20 H. KONDO et al. GJcK Glucose + ATP -~ Glucose-6-phosphate -I-ADP (2) G6PDH Glucose-6-phosphate + NADP+ -- 6-Phosphogluconolactone+NADPH+ H+ ( 3 ) G1cK from B. stearothermophilus is similar to HK in the enzymic reaction, but has the following advantages over it in addition to the high thermal stability [17] : (a) high substrate specificity to glucose, (b) low Michaelis constant for ATP, (c) good stability at room temperature, (d) no adenosine triphosphatase activity. Furthermore, we found the combination of G1cK obtained from B. stearothermo- philus and G6PDH obtained from L. mesenteroides very useful in the measurement of CK activity, from the finding that the stability of G 6PDH was higher in the G1cK-G6PDH method than in the HK-G6PDH method. Stability of the working solution For the practical application of a reagent, the stability of the working solution is one of the important factors. At first, we examined the stability of the working solution with the single reagent. The CK activity of given serum samples was found to be fully recovered when tested in a reagent mixture that had been stored for at least 2 days at 30°C. This reagent stability is considered to be superior to that found with the usual HK-G6PDH method (less than several hours), being mainly ascribed to the use of the thermostable G1cK. In fact, G1cK was found to be stable for about 8-10 days at 30°C in the reagent mixture. As the result of the determination of the residual amounts of G6PDH, NADP+, creatine phos- phate, and NAC in the reagent mixture, creatine phosphate was found to be the most unstable component, with the residual amount of it being about 50% after storage for 8 days at 30°C.
Recommended publications
  • METACYC ID Description A0AR23 GO:0004842 (Ubiquitin-Protein Ligase
    Electronic Supplementary Material (ESI) for Integrative Biology This journal is © The Royal Society of Chemistry 2012 Heat Stress Responsive Zostera marina Genes, Southern Population (α=0.
    [Show full text]
  • Creatine Kinase Assay Kit
    Creatine Kinase Assay Kit Catalog Number KA1665 100 assays Version: 03 Intended for research use only www.abnova.com Table of Contents Introduction ................................................................................................... 3 Intended Use ................................................................................................................. 3 Background ................................................................................................................... 3 Principle of the Assay .................................................................................................... 3 General Information ...................................................................................... 4 Materials Supplied ......................................................................................................... 4 Storage Instruction ........................................................................................................ 4 Materials Required but Not Supplied ............................................................................. 4 Precautions for Use ....................................................................................................... 4 Assay Protocol .............................................................................................. 5 Reagent Preparation ..................................................................................................... 5 Sample Preparation ......................................................................................................
    [Show full text]
  • Labeled in Thecourse of Glycolysis, Since Phosphoglycerate Kinase
    THE STATE OF MAGNESIUM IN CELLS AS ESTIMATED FROM THE ADENYLATE KINASE EQUILIBRIUM* BY TRWIN A. RoSE THE INSTITUTE FOR CANCER RESEARCH, PHILADELPHIA Communicated by Thomas F. Anderson, August 30, 1968 Magnesium functions in many enzymatic reactions as a cofactor and in com- plex with nucleotides acting as substrates. Numerous examples of a possible regulatory role of Mg can be cited from studies with isolated enzymes,'- and it is known that Mg affects the structural integrity of macromolecules such as trans- fer RNA" and functional elements such as ribosomes.'0 The major problem in translating this information on isolated preparations to the functioning cell is the difficulty in determining the distribution of Mg and the nucleotides among the free and complexed forms that function in the region of the cell for which this information is desired. Nanningall based an attempt to calculate the free Mg2+ and Ca2+ ion concentrations of frog muscle on the total content of these metals and of the principal known ligands (adenosine 5'-triphosphate (ATP), creatine-P, and myosin) and the dissociation constants of the complexes. However, this method suffers from the necessity of evaluating the contribution of all ligands as well as from the assumption that all the known ligands are contributing their full complexing capacity. During studies concerned with the control of glycolysis in red cells and the control of the phosphoglycerate kinase step in particular, it became important to determine the fractions of the cell's ATP and adenosine 5'-diphosphate (ADP) that were present as Mg complexes. Just as the problem of determining the distribution of protonated and dissociated forms of an acid can be solved from a knowledge of pH and pKa of the acid, so it would be possible to determine the liganded and free forms of all rapidly established Mg complexes from a knowledge of Mg2+ ion concentration and the appropriate dissociation constants.
    [Show full text]
  • 1 Metabolic Dysfunction Is Restricted to the Sciatic Nerve in Experimental
    Page 1 of 255 Diabetes Metabolic dysfunction is restricted to the sciatic nerve in experimental diabetic neuropathy Oliver J. Freeman1,2, Richard D. Unwin2,3, Andrew W. Dowsey2,3, Paul Begley2,3, Sumia Ali1, Katherine A. Hollywood2,3, Nitin Rustogi2,3, Rasmus S. Petersen1, Warwick B. Dunn2,3†, Garth J.S. Cooper2,3,4,5* & Natalie J. Gardiner1* 1 Faculty of Life Sciences, University of Manchester, UK 2 Centre for Advanced Discovery and Experimental Therapeutics (CADET), Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, UK 3 Centre for Endocrinology and Diabetes, Institute of Human Development, Faculty of Medical and Human Sciences, University of Manchester, UK 4 School of Biological Sciences, University of Auckland, New Zealand 5 Department of Pharmacology, Medical Sciences Division, University of Oxford, UK † Present address: School of Biosciences, University of Birmingham, UK *Joint corresponding authors: Natalie J. Gardiner and Garth J.S. Cooper Email: [email protected]; [email protected] Address: University of Manchester, AV Hill Building, Oxford Road, Manchester, M13 9PT, United Kingdom Telephone: +44 161 275 5768; +44 161 701 0240 Word count: 4,490 Number of tables: 1, Number of figures: 6 Running title: Metabolic dysfunction in diabetic neuropathy 1 Diabetes Publish Ahead of Print, published online October 15, 2015 Diabetes Page 2 of 255 Abstract High glucose levels in the peripheral nervous system (PNS) have been implicated in the pathogenesis of diabetic neuropathy (DN). However our understanding of the molecular mechanisms which cause the marked distal pathology is incomplete. Here we performed a comprehensive, system-wide analysis of the PNS of a rodent model of DN.
    [Show full text]
  • The Characterization of Human Adenylate Kinases 7 and 8
    The characterization of human adenylate kinases 7 and 8 demonstrates differences in kinetic parameters and structural organization among the family of adenylate kinase isoenzymes Christakis Panayiotou, Nicola Solaroli, Yunjian Xu, Magnus Johansson, Anna Karlsson To cite this version: Christakis Panayiotou, Nicola Solaroli, Yunjian Xu, Magnus Johansson, Anna Karlsson. The char- acterization of human adenylate kinases 7 and 8 demonstrates differences in kinetic parameters and structural organization among the family of adenylate kinase isoenzymes. Biochemical Journal, Port- land Press, 2011, 433 (3), pp.527-534. 10.1042/BJ20101443. hal-00558097 HAL Id: hal-00558097 https://hal.archives-ouvertes.fr/hal-00558097 Submitted on 21 Jan 2011 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Biochemical Journal Immediate Publication. Published on 16 Nov 2010 as manuscript BJ20101443 The characterization of human adenylate kinases 7 and 8 demonstrates differences in kinetic parameters and structural organization among the family of adenylate kinase isoenzymes
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2010/0317005 A1 Hardin Et Al
    US 20100317005A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2010/0317005 A1 Hardin et al. (43) Pub. Date: Dec. 16, 2010 (54) MODIFIED NUCLEOTIDES AND METHODS (22) Filed: Mar. 15, 2010 FOR MAKING AND USE SAME Related U.S. Application Data (63) Continuation of application No. 11/007,794, filed on Dec. 8, 2004, now abandoned, which is a continuation (75) Inventors: Susan H. Hardin, College Station, in-part of application No. 09/901,782, filed on Jul. 9, TX (US); Hongyi Wang, Pearland, 2001. TX (US); Brent A. Mulder, (60) Provisional application No. 60/527,909, filed on Dec. Sugarland, TX (US); Nathan K. 8, 2003, provisional application No. 60/216,594, filed Agnew, Richmond, TX (US); on Jul. 7, 2000. Tommie L. Lincecum, JR., Publication Classification Houston, TX (US) (51) Int. Cl. CI2O I/68 (2006.01) Correspondence Address: (52) U.S. Cl. ............................................................ 435/6 LIFE TECHNOLOGES CORPORATION (57) ABSTRACT CFO INTELLEVATE Labeled nucleotide triphosphates are disclosed having a label P.O. BOX S2OSO bonded to the gamma phosphate of the nucleotide triphos MINNEAPOLIS, MN 55402 (US) phate. Methods for using the gamma phosphate labeled nucleotide are also disclosed where the gamma phosphate labeled nucleotide are used to attach the labeled gamma phos (73) Assignees: LIFE TECHNOLOGIES phate in a catalyzed (enzyme or man-made catalyst) reaction to a target biomolecule or to exchange a phosphate on a target CORPORATION, Carlsbad, CA biomolecule with a labeled gamme phosphate. Preferred tar (US); VISIGEN get biomolecules are DNAs, RNAs, DNA/RNAs, PNA, BIOTECHNOLOGIES, INC. polypeptide (e.g., proteins enzymes, protein, assemblages, etc.), Sugars and polysaccharides or mixed biomolecules hav ing two or more of DNAs, RNAs, DNA/RNAs, polypeptide, (21) Appl.
    [Show full text]
  • Structures, Functions, and Mechanisms of Filament Forming Enzymes: a Renaissance of Enzyme Filamentation
    Structures, Functions, and Mechanisms of Filament Forming Enzymes: A Renaissance of Enzyme Filamentation A Review By Chad K. Park & Nancy C. Horton Department of Molecular and Cellular Biology University of Arizona Tucson, AZ 85721 N. C. Horton ([email protected], ORCID: 0000-0003-2710-8284) C. K. Park ([email protected], ORCID: 0000-0003-1089-9091) Keywords: Enzyme, Regulation, DNA binding, Nuclease, Run-On Oligomerization, self-association 1 Abstract Filament formation by non-cytoskeletal enzymes has been known for decades, yet only relatively recently has its wide-spread role in enzyme regulation and biology come to be appreciated. This comprehensive review summarizes what is known for each enzyme confirmed to form filamentous structures in vitro, and for the many that are known only to form large self-assemblies within cells. For some enzymes, studies describing both the in vitro filamentous structures and cellular self-assembly formation are also known and described. Special attention is paid to the detailed structures of each type of enzyme filament, as well as the roles the structures play in enzyme regulation and in biology. Where it is known or hypothesized, the advantages conferred by enzyme filamentation are reviewed. Finally, the similarities, differences, and comparison to the SgrAI system are also highlighted. 2 Contents INTRODUCTION…………………………………………………………..4 STRUCTURALLY CHARACTERIZED ENZYME FILAMENTS…….5 Acetyl CoA Carboxylase (ACC)……………………………………………………………………5 Phosphofructokinase (PFK)……………………………………………………………………….6
    [Show full text]
  • Regulation of Adenylate Kinase and Creatine Kinase Activities In
    Proc. Nat. Acad. Sci. USA Vol. 71, No. 6, pp. 2377-2381, June 1974 Regulation of Adenylate Kinase and Creatine Kinase Activities in Myogenic Cells (myogenesis/enzyme regulation) HELGI TARIKAS AND DAVID SCHUBERT Neurobiology Department, The Salk Institute, P. 0. Box 1809, San Diego, Califdr.nia 92112 Communicated by F. Jacob, March 8, 1974 ABSTRACT The regulation of the specific activities of not fuse in either situation. M3A shows a hyperpolarizing adenylate kinase (EC 2.7.4.3) and creatine kinase (EC response to iontophoretically applied acetylcholine compa- 2.7.3.2) in myogenic cell lines is independent of cell fusion. The observed increases in enzyme specific activities are cell rable to that observed in L6 myoblasts (A. J. Harris, personal density dependent, and may be further broken down into communication). The creatine kinase isozymes (8) of L6 and contributions from an increase in enzyme activity per cell M3A are indistinguishable. All cells were cultured in modified and a decrease in protein per cell. Only the former appears Eagle's medium (9) containing 10% fetal-calf serum at 360. to be affected by medium conditioning. Falcon plastic tissue culture or petri dishes were used as There is an increase in the specific activities (enzyme activity indicated. Cell number determinations and assays for creatine per unit of total cellular protein) of adenylate kinase (EC kinase and adenylate kinase were done as described (10). 2.7.4.3; ATP:AMP phosphotransferase) and creatine kinase Cells were dissociated for cell number determinations and (EC 2.7.3.2; ATP: creatine N-phosphotransferase) temporally replating with 0.25% (w/v) Viokase (Gibco).
    [Show full text]
  • AMP-Activated Protein Kinase: Screening for Novel Membrane
    AMP-activated protein kinase : Screening for novel membrane substrates and creatine kinase phosphorylation linked to specific subcellular compartment Sacnicte Ramirez Rios To cite this version: Sacnicte Ramirez Rios. AMP-activated protein kinase : Screening for novel membrane substrates and creatine kinase phosphorylation linked to specific subcellular compartment. Cellular Biology. Université de Grenoble, 2010. English. tel-00641109 HAL Id: tel-00641109 https://tel.archives-ouvertes.fr/tel-00641109 Submitted on 14 Nov 2011 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. THÈSE Pour obtenir le grade de DOCTEUR DE L’UNIVERSITÉ DE GRENOBLE Spécialité : Biologie Cellulaire Arrêté ministériel : 7 août 2006 Présentée par Sacnicte RAMIREZ RIOS Thèse dirigée par Uwe SCHLATTNER préparée au sein du Laboratoire de Bioénergétique Fondamentale et Appliquée dans l'École Doctorale Chimie et Sciences du Vivant La protéine kinase activée par AMP : Criblage de nouveaux substrats membranaires et phosphorylation de la créatine kinase liée à une compartimentation subcellulaire Thèse soutenue publiquement le « 20 décembre 2010 », devant le jury composé de : Pr. Theo WALLIMANN Professeur à l’ETH Hönggerberg HPM, (Rapporteur) Pr. Bé WIERINGA Professeur, Department of Cell Biology, Nijmegen University (Rapporteur) Dr. Marie-Lise LACOMBE Professeur INSERM UMRS (Examinateur) Pr.
    [Show full text]
  • Education Creatine Kinase (Total) Test
    Education Creatine Kinase (Total) Test What is the total creatine kinase test? This test measures an enzyme in the blood. The enzyme is called creatine kinase (CK). Muscle cells make this enzyme. When muscle cells are injured or diseased, enzymes leak out of the cells and enter the bloodstream. Why is this test done? The CK test can show if muscles have been injured. It also gives an idea of how bad the injury is, when it happened, and whether it is healing. The test may be done to: Find out if you have had a heart attack (myocardial infarction). Diagnose chest pain. Look for other muscle injuries or disease, such as muscular dystrophy or rhabdomyolysis. Check blood flow to the heart after heart surgery or other treatments that affect the heart muscle. If this test shows that some muscle has been injured, other tests may also be done to see which muscles are injured. How do I prepare for this test? If you are being checked for problems with your skeletal muscles, do not exercise for 24 hours before the test. You may need to avoid taking certain medicines before the test because they might affect the test result. Make sure your health care provider knows about any medicines, herbs, or supplements that you are taking. Don't stop any of your regular medicines without first consulting with your health care provider. Talk to your health care provider if you have any other questions. How is the test done? A small amount of blood is taken from your arm with a needle.
    [Show full text]
  • Neuroprotective Effects of Creatine and Cyclocreatine in Animal Models of Huntington’S Disease
    The Journal of Neuroscience, January 1, 1998, 18(1):156–163 Neuroprotective Effects of Creatine and Cyclocreatine in Animal Models of Huntington’s Disease Russell T. Matthews,1 Lichuan Yang,1 Bruce G. Jenkins,1 Robert J. Ferrante,2 Bruce R. Rosen,1 Rima Kaddurah-Daouk3 and M. Flint Beal1 1Neurochemistry Laboratory, Neurology Service and Massachusetts General Hospital Nuclear Magnetic Resonance Center, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, 2Geriatric Research Educational and Clinical Center, Bedford Veterans Administration Medical Center, Department of Neurology and Pathology, Boston University School of Medicine, Boston, Massachusetts 02115, and 3The Avicena Group, Inc., Cambridge, Massachusetts 02139 The gene defect in Huntington’s disease (HD) may result in produced by 3-NP.Creatine supplementation protected against an impairment of energy metabolism. Malonate and 3-NP induced increases in striatal lactate concentrations in vivo 3-nitropropionic acid (3-NP) are inhibitors of succinate dehy- as assessed by 1H magnetic resonance spectroscopy. Creatine drogenase that produce energy depletion and lesions that and cyclocreatine protected against malonate-induced in- closely resemble those of HD. Oral supplementation with cre- creases in the conversion of salicylate to 2,3- and 2,5- atine or cyclocreatine, which are substrates for the enzyme dihydroxybenzoic acid, biochemical markers of hydroxyl radical creatine kinase, may increase phosphocreatine (PCr) or phos- generation.
    [Show full text]
  • Changes in the Enzymes ALT, CK and AST During the Acute
    Full Article Rev. Bras. Parasitol. Vet., Jaboticabal, v. 21, n. 3, p. 243-248, jul.-set. 2012 ISSN 0103-846X (impresso) / ISSN 1984-2961 (eletrônico) Rangelia vitalii: changes in the enzymes ALT, CK and AST during the acute phase of experimental infection in dogs Rangelia vitalii: mudanças nas enzimas ALT, CK e AST na fase aguda da infecção experimental em cães Márcio Machado Costa1*; Raqueli Teresinha França1; Aleksandro Schafer Da Silva2; Carlos Breno Paim1, Francine Paim1; Carlos Henrique do Amaral3; Guilherme Lopes Dornelles1; João Paulo Monteiro Carvalho Mori da Cunha1; João Fabio Soares4; Marcelo Bahia Labruna4; Cinthia Melazzo Andrade Mazzanti1; Silvia Gonzalez Monteiro2; Sonia Terezinha dos Anjos Lopes1 1Department of Small Animals, Federal University of Santa Maria – UFSM, Santa Maria, RS, Brazil 2Department of Microbiology and Parasitology, Federal University of Santa Maria – UFSM, Santa Maria, RS, Brazil 3Department of Veterinary Medicine, Federal University of Paraná – UFPR, Curitiba, PR, Brazil 4Department of Preventive Veterinary Medicine and Animal Health, University of São Paulo – USP, Brazil Received October 27, 2011 Accepted June 8, 2012 Abstract Rangelia vitalii is a protozoon that causes diseases in dogs, and anemia is the most common laboratory finding. However, few studies on the biochemical changes in dogs infected with this protozoon exist. Thus, this study aimed to investigate the biochemical changes in dogs experimentally infected with R. vitalii, during the acute phase of the infection. For this study, 12 female dogs (aged 6-12 months and weighing between 4 and 7 kg) were used, divided in two groups. Group A was composed of healthy dogs (n = 5); and group B consisted of infected animals (n = 7).
    [Show full text]